Suraksha Diagnostic Share Price Today

Suraksha Diagnostic AGM: All resolutions passed, director re-appointment sees 10% dissent

Shareholders approved all five resolutions at the 21st AGM held on September 22, 2026. Final dividend of ₹0.50 per equity share declared for FY26. Re-appointment of director Satish Kumar Verma passed with 90.08% support, seeing 9.92% dissent. Institutional investors cast 22.70% of their votes against the director's re-appointment. Total votes polled across resolutions ranged between 36.69 million and 42.34 million.

Suraksha Diagnostic updates AGM voting dates for September 2026

Suraksha Diagnostic updates its 21st AGM e-voting window to September 18–21, 2026. Record date for voting eligibility shifted to September 15, 2026. Board maintains proposed final dividend of ₹0.50 per share for FY26. AGM scheduled for September 22, 2026, via video conferencing.

Suraksha Diagnostic Q1FY27 PAT up 40% to ₹128 crore, EBITDA margin expands

Suraksha Diagnostic Limited reported a consolidated net profit of ₹128 crore for Q1FY27, up 40% year-on-year. Total income rose 21% to ₹887 crore, with EBITDA growing 28% to ₹315 crore. EBITDA margin expanded to 36% from 34%, driven by operating leverage and improved cost management. The company added new centers in Jharkhand and plans to reach 100 centers by FY28. Genomics revenue surged 136% YoY to ₹13.7 million.

Suraksha Diagnostic releases Q4FY26 earnings call audio for investor review

Suraksha Diagnostic Limited released the audio recording of its earnings call held on August 13, 2026. The call discussed unaudited standalone and consolidated financial results for Q4FY26. The disclosure complies with SEBI LODR Regulations 30(6) and 46(2).

Suraksha Diagnostic Q1 Results: Net profit up 28% YoY to ₹125.8 lakh

Suraksha Diagnostic Ltd posted a strong Q1FY26 with standalone net profit up 27.6% YoY to ₹125.8 lakh and consolidated profit up 38.6%. Revenue grew nearly 20% across both metrics. The board appointed Dinesh Gupta as CFO and set Sept 15 as the dividend record date.

Suraksha Diagnostic postpones 21st AGM scheduled for Sep 2, 2026

Suraksha Diagnostic Limited postponed its 21st AGM, set for September 02, 2026, citing unavoidable circumstances. The company notified exchanges on August 10, 2026, promising a future update on the new date in compliance with SEBI regulations and the Companies Act, 2013.